Alexander de Leeuw
is a senior associate and specialises in national and international patent litigation, with a special focus on pharmaceutical inventions, medical devices and consumer goods. He also regularly deals with the protection of know-how/trade secrets and evidentiary seizures. Alexander has gained significant experience litigating in complex patent cases before the courts in The Hague and the EPO, eg, concerning pemetrexed and CRISPR-Cas9. In addition to his litigation practice, Alexander enjoys writing and teaching about patent law and regularly publishes about the developments regarding trade secrets, software patents and artificial intelligence.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.